Next Article in Journal
Multi-Mycotoxin Method Development Using Ultra-High Liquid Chromatography with Orbitrap High-Resolution Mass Spectrometry Detection in Breakfast Cereals from the Campania Region, Italy
Next Article in Special Issue
The Efficacy of Transvaginal Ultrasound-Guided BoNT-A External Sphincter Injection in Female Patients with Underactive Bladder
Previous Article in Journal
E-Nose Technology for Mycotoxin Detection in Feed: Ready for a Real Context in Field Application or Still an Emerging Technology?
Previous Article in Special Issue
Shear Wave Velocity to Evaluate the Effect of Botulinum Toxin on Post-Stroke Spasticity of the Lower Limb
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review

Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60121 Ancona, Italy
*
Author to whom correspondence should be addressed.
Toxins 2023, 15(2), 147; https://doi.org/10.3390/toxins15020147
Submission received: 30 November 2022 / Revised: 22 January 2023 / Accepted: 9 February 2023 / Published: 11 February 2023
(This article belongs to the Special Issue Clinical and Anatomical Perspectives of Botulinum Neurotoxin)

Abstract

Botulinum toxin type B (BoNT-B), known as Myobloc® in the United States and as Neurobloc® in Europe, is a new therapeutically available serotype among the botulinum toxin family. During the last years several data have been reported in literature investigating its efficacy and safety, as well as defining the dosing and application regiments of BoNT-B in the treatment of hyperhidrosis. Moreover, recent studies have been examining its safety profile, which may be different from those known about BoNT-A. The aim of this review is to provide information about what is currently known about BoNT-B in regards to the treatment of focal hyperhidrosis.
Keywords: botulinum toxin type B; focal hyperhidrosis; palmar hyperhidrosis; axillary hyperhidrosis; craniofacial hyperhidrosis; plantar hyperhidrosis; compensatory hyperhidrosis; residual hyperhidrosis botulinum toxin type B; focal hyperhidrosis; palmar hyperhidrosis; axillary hyperhidrosis; craniofacial hyperhidrosis; plantar hyperhidrosis; compensatory hyperhidrosis; residual hyperhidrosis

Share and Cite

MDPI and ACS Style

Campanati, A.; Diotallevi, F.; Radi, G.; Martina, E.; Marconi, B.; Bobyr, I.; Offidani, A. Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review. Toxins 2023, 15, 147. https://doi.org/10.3390/toxins15020147

AMA Style

Campanati A, Diotallevi F, Radi G, Martina E, Marconi B, Bobyr I, Offidani A. Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review. Toxins. 2023; 15(2):147. https://doi.org/10.3390/toxins15020147

Chicago/Turabian Style

Campanati, Anna, Federico Diotallevi, Giulia Radi, Emanuela Martina, Barbara Marconi, Ivan Bobyr, and Annamaria Offidani. 2023. "Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review" Toxins 15, no. 2: 147. https://doi.org/10.3390/toxins15020147

APA Style

Campanati, A., Diotallevi, F., Radi, G., Martina, E., Marconi, B., Bobyr, I., & Offidani, A. (2023). Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review. Toxins, 15(2), 147. https://doi.org/10.3390/toxins15020147

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop